Added to YB: 2025-10-13
Pitch date: 2025-10-09
HROW [neutral]
Harrow, Inc.
+12.15%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
Market Cap
$1.6B
Pitch Price
$40.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
38.20
P/E
-324.83
EV/Sales
7.29
Sector
Pharmaceuticals
Category
growth
3 Small Caps I'm Watching Closely - Harrow, Inc.
HROW (watchlist): Ophthalmology pharma w/ 31% rev growth, 116% EBITDA growth, 75% gross margins, 25% EBITDA margins. Targets $250M quarterly rev by FY27 ($1B annual). Trading 4.9x NTM sales despite 52% rev CAGR potential. Aging population + screen time drive TAM expansion for eye procedures.
Read full article (1 min)